Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Publication Date Organization
Apr
2
2025
 USDA Will Fund 543 Projects in 29 States Through Higher Blends Infrastructure Incentive Program Bergeson & Campbell, P.C.
Apr
2
2025
 GLP-1 Receptor Agonists: Drug Litigation Overview and Trends Foley & Lardner LLP
Apr
2
2025
 March 2025 PFAS Legislative Developments CMBG3 Law
Apr
2
2025
 Texas Court Vacates FDA’s Laboratory Developed Test (LDT) Final Rule Foley & Lardner LLP
Apr
1
2025
 In Landmark Ruling, Eastern District of Texas Strikes Down FDA’s Final Rule Regulating Laboratory Developed Tests Polsinelli PC
Apr
1
2025
 New Mexico Bills Would Expand Protections for Medical Marijuana and Allow Use of Medical Psilocybin Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Apr
1
2025
 EC Begins Public Consultation on Upcoming EU Bioeconomy Strategy Bergeson & Campbell, P.C.
Apr
1
2025
 Updates on SB 54: CalRecycle to Take a Second Stab at Implementing Regulations K&L Gates LLP
Apr
1
2025
 A Final Rule Bites the Dust: Federal Court Rules FDA Lacks Authority to Regulate LDTs Epstein Becker & Green, P.C.
Apr
1
2025
 FDA Can’t Stop, Won’t Stop – Navigating the New Administration [Podcast] Keller and Heckman LLP
Apr
1
2025
 We Never Know How High We Are Until We Are Called to Rise: Protecting Alabama’s Medical Cannabis Program Bradley Arant Boult Cummings LLP
Apr
1
2025
 FDA Announces “Operation Stork Speed” Keller and Heckman LLP
Apr
1
2025
 FDA’s New Transparency Tool Addresses Chemical Contaminants Sheppard, Mullin, Richter & Hampton LLP
Mar
31
2025
 New Guidelines Establishing the Requirements and Procedures That Must Be Observed to Obtain Permission to Advertise Prepackaged Food and Non-Alcoholic Beverages OLIVARES
Mar
31
2025
 APHIS Evaluates Petitions Reviewed under 2012 Process, Will Use Process Consistent with USDA Biotechnology Regulations Going Forward Bergeson & Campbell, P.C.
Mar
28
2025
 HHS Job Cuts: FDA, CDC, NIH and CMS Impacted Amidst Significant Restructurings Polsinelli PC
Mar
28
2025
 Nebraska Considers Sales Tax on Candy and Soft Drinks Keller and Heckman LLP
Mar
28
2025
 FDA Announces a “Chemical Contaminants Transparency Tool” to Evaluate Potential Health Risks of Contaminants in Human Foods. Keller and Heckman LLP
Mar
28
2025
 Illinois Moving Forward with BVO Ban Keller and Heckman LLP
Mar
27
2025
 Behavioral Health Law Ledger | March 2025 Greenberg Traurig, LLP
Mar
27
2025
 EPA Extends 2024 RFS Compliance Reporting Deadline Bergeson & Campbell, P.C.
Mar
27
2025
 CLP Changes And What They Mean For Commercial Operations — A Conversation with Karin Baron and Lioba Oerter [Podcast] Bergeson & Campbell, P.C.
Mar
27
2025
 China Releases New Rules Regarding the Use of Facial Recognition Technology Hunton Andrews Kurth
Mar
27
2025
 What’s the (Re)issue? Patent Term Extensions for Reissue Patents McDermott Will & Emery
Mar
27
2025
 China Releases Draft Implementation Measures for the Protection of Drug Trial Data Including Data Exclusivity for Foreign-Originated Drugs Schwegman, Lundberg & Woessner, P.A.
Mar
26
2025
 Ghost Guns and the Bankruptcy Code: Neither Provides Ammunition for Dismissing Actions - SCOTUS Today Epstein Becker & Green, P.C.
Mar
26
2025
 This Week in 340B: March 18 – 24, 2025 McDermott Will & Emery
Mar
25
2025
 DEA Buprenorphine Rule Delayed to December 31, 2025 Foley & Lardner LLP
Displaying 1 - 28 of 12100
Subscribe to The 10 Latest Biological, Life Sciences, and Cleantech Law Articles
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters